Send a Text to the Moms - please include your contact info if you want a response. thanks! The podcast episode featured a discussion with Dr. Martijn Figee and Dr. Alexander Charney from the Icahn School of Medicine at Mount Sinai about deep brain stimulation (DBS) as a potential treatment for schizophrenia. The doctors explained that DBS is a neurosurgical procedure involving the implantation of electrodes to target specific brain circuits, offering a durable treatment option for severe, treatment-resistant symptoms like hallucinations and delusions. They shared that initial results from a small number of patients have been promising, with some experiencing immediate and significant symptom reduction. The treatment is currently in the experimental stage, with ongoing clinical trials at Mount Sinai and Johns Hopkins. The ideal patient for DBS would have chronic, medication-resistant symptoms and the ability to provide informed consent and comply with follow-up care. The conversation also touched on the challenges of schizophrenia research, the hope for future advancements, and the importance of participation in studies and brain donation for scientific progress. Link: https://icahn.mssm.edu/research/blau Mindy and her book: https://mindygreiling.com/ Randye and her book: https://randyekaye.com/ Miriam and her book: https://www.miriam-feldman.com/ Thanks for liking and sharing the podcast! Support the show Please share and support the podcast so we can reach more people who need the info and support. Want to know more? Join our facebook page Our websites: Randye Kaye Mindy Greiling Miriam (Mimi) Feldman
Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.
Transcript
From the show. Tap a time to play from there.
SPEAKER_01Treatments that could be miraculous in other brain conditions. Well, here's the brain condition that puzzles us the most. We can't look away from DBS. We have to say, okay, can DBS be effective for schizophrenia? And then it just takes someone to be the first to try.
SPEAKER_05When you've seen what Alex and I've seen in these acute dramatic responses in patients with a well-placed electrode into their brain, that's so enormously motivating. Whenever I see a patient, doesn't matter how severe, I'm always motivated because I know in the end there is a solution.
SPEAKER_02For families who've wondered what happens when nothing else works, today's conversation offers a glimpse of hope grounded in science. We're talking with two leading psychiatrists about deep brain stimulation and what it could mean for the future of schizophrenia treatment. Welcome to our podcast, Schizophrenia Three Moms in the Trenches. From the place where schizophrenia and real life collide.
SPEAKER_02With Miriam Feldman, Mindy Gryling, and Randy Kay. Here at Schizophrenia Three Moms in the Trenches, our listeners are always asking us for hope. And in that hope is often the latest developments in treatment. And so in this episode, we're going to talk about something called deep brain stimulation, which I don't know anything about it, but we are about to learn. And we're, you know, if you're new to the podcast, first of all, welcome.
SPEAKER_02We three hosts are three moms. We each have a son with schizophrenia. We've each written a book about it. And this is episode 143. We continue to gain new followers who say, Where have you been? So you will honor us by spreading the word and letting people know that we are here to help. This episode, we have various categories. Sometimes we tell stories, sometimes we share emotions, sometimes we interview other listeners.
SPEAKER_02And today we are going to talk about more medical and schizophrenia and treatment information. And the deep brain stimulation is what we're going to talk about. So with us today are um Dr. Martine Figee and Dr. Alexander Charney, who are the experts or experts in there. And they were recommended by a friend of the podcast, Dr. Rob Layton, who's with us, but not really going to be wholly participating.
SPEAKER_02It's just going to be a fly on the wall. So, Rob, you can sing hi to our listeners. And if you're watching on YouTube, then he's going to turn his camera off. You won't see him, but he might pop in from time to time. Dr. Alexander Charney is a physician scientist and leader at the Icon School of Medicine at Mount Sinai. Dr. Martine Figui is a psychiatrist and professor of psychiatry at the same place, the Icon School of Medicine at Mount Sinai. So I'm going to dive right in with the first question.
SPEAKER_02And Mimi, I'm going to email you the questions because I see that you don't have them. So they are literally just did. So we did that. All right.
SPEAKER_03We need to be a little more subtle about that, but we're not subtle here on the podcast.
SPEAKER_02It's very, very grassroots. And speaking of that, thank you to those of us who have uh clicked the link on our show notes and offered to support the podcast with a small monthly donation. This way we can spread the word and keep doing what we're doing. And we so appreciate every single one of you, whether you're a supporter or not. So um, Martine and Alex, uh, for those hearing about deep brain stimulation, DBS for the first time, and that includes me. I don't know if Mindy or Mimi know anything about it, but this is the first time for me.
SPEAKER_02Like, what is it? And and how is it different from treatments like medication or ECT, electroconvulsive therapy? Uh, whoever wants to start can start.
SPEAKER_05Okay, so yeah, deep brain simulation works with people that have actually tried medications, and you need to realize that medications interfere with the electricity of the brain through neurotransmitters, but unfortunately, the brain sometimes can work around uh uh manipulating the manipulation of those neurotransmitters, so that's when you start to intervene in the electricity itself. And yes, electroshocks or ECT is kind of a rough way to do that, it kind of resets the brain through direct electricity from the outside, but deep brain stimulation does so in a more intricate way, it goes after very specific circuits by implanted leads or wires that are connected to implanted pacemakers in the chest, so to uh correct these abnormal circuits, at least the abnormal firing in the circuit.
SPEAKER_05And that's um a very durable option for basal ganglia disorders that involve abnormal movements, which is tremor and Parkinson's, but it's also more and more a treatment that's now being uh examined, tested for psychiatric diseases, so it has obsessive compulsive disorder, depression, um, but also schizophrenia.
SPEAKER_04Do you see um this replacing ECT at some point that there are they complementary in some way?
SPEAKER_05ECT is very helpful acutely, it can help you acutely um get out of a very severe suicidal depression or a psychosis, but unfortunately it's not durable, right? It's because it's kind of a shock of the brain, you seizure the brain, the brain resets, and then unfortunately, a couple of months later, symptoms may re-occur, which actually often happens after ECT. So it can be a very good treatment to get you out of a really severe brain state.
SPEAKER_05Um, but if you want something durable, then the brain stimulation is the is it's just the only it's not even an alternative, that's just the only option. It's the only option we have that can correct brain activity in a durable way, in a sustained way.
SPEAKER_03Is it used in conjunction with uh medication or by itself?
SPEAKER_05I think several of our patients, for example, with depression and OCD, they've been able to completely uh get rid of any medication. So in theory, that that should be possible. We've tried it now in a few patients with schizophrenia, they've drastically come down in their medications, but I I would say all of them still have like a minimal dose of uh of antipsychotic uh medications.
SPEAKER_02Um, Alex may thank you so much. Alex, maybe you can answer this for me. So since I know nothing about it, we know nothing about it, like we've all seen versions of ECT in movies and documentaries, and it's probably very inaccurate, but I want to talk about deep brain stimulation. You know, I I guess you're using it already. So what's that like for the patient? Like, what exactly is it? What does the pay what does the patient go through in order for this to be a treatment for them?
SPEAKER_01Yeah, this is a great question. And uh, you know, stepping back, just want to thank you for having us. Uh it's really an honor for us to be here. Um, you know, as schizophrenia physicians and and and researchers uh to be you know invited to a podcast by three people who have such personal experience in schizophrenia, and and it's really just super exciting for us to be here. So thank you. And um, you know, the first the first part of of you know, when I think about what the experience again, so so few patients with schizophrenia have actually gone through this.
SPEAKER_01Um, you know, so I'm just you know kind of putting myself in the in the in the seat of a patient who has schizophrenia who's you know considering um deep brain stimulation as an option. And the first thing is it's it's a neurosurgery. Um you know, it's it's a brain surgery. It's it's it's it's very different than any other type of medication or treatment that someone with um with schizophrenia or a family member of someone with schizophrenia has has likely considered before. Um you know, undergoing a surgical procedure is is is is is uh you know it's it's not something to be to be too scared of or or to be overly you know uh scared of or scared away from.
SPEAKER_01Um but but it is different than, for instance, being started on a pill. So that's I think the first part of the experience is just getting used to the idea that we're talking about brain surgery here and um getting over maybe the initial um you know trepidation or or or fear of what that actually means. And and as I've you know in my own in my own life come to understand, I'm not I'm not a DBS expert in in the way that Mark uh Martin Dr. Frigy is. Um I'm I'm more of a general schizophrenia researcher myself, but as I've I've come to understand how DBS works and what the experience is like for for patients, uh I think a an important step is getting over that initial kind of mystery of oh, brain surgery.
SPEAKER_01That sounds really scary. You know, as many people who who know someone with schizophrenia uh have experienced, sometimes in schizophrenia, um a part of the illness may be ideas about something being implanted into your brain. And that that's not an uncommon um symptom in schizophrenia. Um so when we talk about uh actually implanting something into someone's brain as the treatment, um you know, that's a tricky space to operate in. Right. Um, yeah, so that's another another really important thing to just think about right up front.
SPEAKER_01You know, we we are talking about implanting a device into the brain to treat an illness where a common symptom is the idea that something has already been implanted into your brain against your will. Um so I think these are just sort of the the initial um you know you know you know things to come to terms with as a patient who's considering this, uh this experience. And and Dr. Fage uh is is really the best in the world uh at helping patients think through this and and and and and guide them through um you know this experience because even though this is a new treatment for schizophrenia, it's not a new treatment uh in general.
SPEAKER_01Many patients with other illnesses have have received um you know this this this um uh this this therapy. And then you know the experience from there is uh you get assessed uh to see if you're a good candidate. And and and and Dr. Frigge can talk a bit more about what what that um what that actually looks like and who who is the ideal candidate um for for um uh uh a treatment like this. Um and but if we fast forward assuming the patient is a good candidate and they actually do decide uh uh to move forward with with the treatment, um, you the patient will undergo uh at Mount Sinai, they they would undergo um uh a procedure uh where uh they would uh have have the device uh implanted by a neurosurgeon who's you know done this hundreds or or actually thousands of times.
SPEAKER_01Um and it's a it's a it's a procedure that doesn't, it's not like you'd be in the hospital for a long time. So you kind of come in, you get get the um the device implanted, you spend the night in the hospital, but but but not it's not like a long long hospital stay.
SPEAKER_04And then you are you put to sleep? Are you put to sleep for the procedure?
SPEAKER_01So you you are put to sleep for for parts of it. Um it's important that the patient is awake for certain parts of it as well, um, because part of the procedure for uh putting the device into the brain does involve um some um back and forth between the clinicians and the patient. Um the uh there's no pain or anything like that. They're the way the brain is is is you know, this neurosurgery is one of the few types of surgery um where you can be awake throughout uh because the brain itself doesn't have um pain neurons, um it has every other type of neuron except for the pain neurons.
SPEAKER_01Um yeah, so so um the yeah, that that is that is a part of the experience, is and that's an important question, it kind of being prepared mentally that you will be awake during this procedure for for part of it, which is different than um other surgeries a person uh has has probably had in their life if they've ever had surgery. Um, and then once once the the the uh implantation of the device is over, uh then the patient uh they'll live their life with with um the device as part of who they are.
SPEAKER_01Um you know that's the general idea with with deep brain stimulation, is it becomes a part of you. Um and um the um the the regular meetings with your doctor where the settings of the device are are changed to try and find the settings that work best for you. It's it's like like the dose of your medication is changed. It's the same idea.
SPEAKER_02The dose where is the device? Like the device I imagine is outside of your body. I mean, do you wear it? Where's the device where the settings are?
SPEAKER_01Yeah, oh the f oh uh Dr. Frigid talk about that.
SPEAKER_05Okay, but it's all implanted, so there's a there's a pacemaker-like device in the chest that delivers the stimulation, that's a battery, uh and uh and that delivers the electricity through wires under the skin into the brain, so everything is invisibly uh behind uh the skin inside the body, nothing will be visible so the settings are changed remotely, I guess.
SPEAKER_05Settings can be changed remotely. Typically, patients will have to come in um and they will make some parameter changes. Uh they can hold something against their battery, which will make us connect to their battery, to their pacemaker. Uh, but there's also devices where you can even do that through the Wi-Fi while the patients uh are in their own home setting. But I ideally will do it in the clinics when they're with us.
SPEAKER_04And who is the ideal patient? Is it does it have to be someone young? Could it be anybody? What criteria do you use?
SPEAKER_05I mean, so there's this uh one answer to that question is it has to be um of course severe, uh treatment resistant, right? We wouldn't do this in someone that hasn't exhausted all other options because it is still brain surgery. So that means you need to have tried antipsychotics, including clozopin. Um it helps if you've been able to be compliant with your treatment because now that you have a device implanted, it's of course important to show up with post-surgical wound care, with device parameter changes.
SPEAKER_05If the if a if we send you home with a setting that makes you feel awkward or or even anxious, it's important you'll tell us, right? So those are things that we screen for. Um, so it has to be severe, but still you need to be able to like cognitively and also in terms of insight into your own symptoms to work with us, right? And that's of course important always uh for people for doctors working with patients that suffer from schizophrenia, but it's probably even more important when you work with DBS.
SPEAKER_05And then our trial, at least the trial that we have started with uh Johns Hopkins with Dr. Cassella, who's a uh a schizophrenia expert, uh, who actually initiated this specific target, this specific circuit where we're stimulating seems to be in theory most helpful for hallucinations because it's connecting, at least that's what we make sure. It is it's connected based on our pre-surgical scans that we plan very carefully with our team, our imaging team from Mount Sinai.
SPEAKER_05We make sure that it connects to parts of the of the brain that are involved in auditory hallucinations, the auditory cortex, for example, it also connects to the prefrontal cortex, which is very important in general for control of delusional beliefs and hallucinations, but also just for cognitions in general. So by carefully placing it in that circuit, we expect, or we expected when we designed this trial, that it would be helpful for people with chronic hallucinations despite treatment with antipsychotics, including closure.
SPEAKER_05And they would they would, of course, they needed to be able to give informed consent and and and be compliant with our treatment. That's what we've done so far. Our first patient was a I would say a miracle. I I hadn't expected like such fantastic results, um, because when we turned on the device, uh her hallucinations immediately resolved, like within seconds. Wow, that's something that right. I mean Alex is seeing it.
SPEAKER_01Yeah, this is you know, this is one of the things with deep brain stimulation in general. And you know, talking if I could talk for you know just just you know 30 seconds or so. There's very few things in medicine that when you see them as a doctor, it really has this feeling of a miracle. And uh DBS is one of them. Uh and when it works, it doesn't work in every patient, and it's a new thing for schizophrenia. So, you know, time will tell if this this is you know a robust uh you know signal that we're seeing in the first you know, uh small number of patients that have received this treatment for schizophrenia.
SPEAKER_01But you know, in Parkinson's disease, you in the in the operating room, when the surgeon implants the device and the patient's awake and you see the patient's tremor and you see the device be turned on for the first time, and right in front of your eyes, you see the tremor go away. Right right there in the operating room. Um, it's almost nothing in medicine is like that, where it's like you turn the treatment on and the symptoms just go away in front of your eyes. But but this is something that you see in Parkinson's disease. I've personally seen it happen in Parkinson's disease. I've seen it happen personally in patients with OCD, where you've got patients um yeah, OCD is one of these conditions, uh and Dr.
SPEAKER_01Vicki's, you know, he this is really he's the world's expert in OCD, but it's one of those conditions in the most extreme cases, like like cases that require DBS, um these patients are oftentimes patients washing their hands hundreds of times a day. They can't leave their house. You know, it's so debilitating. And I've seen uh you know the device be turned on and the symptoms go away, like in front of your eyes. Um, so it's it's got this feeling. The miracle is like the word that comes to mind because it's just so dramatic.
SPEAKER_02Wow. Mimi, you want to ask you?
SPEAKER_03Well, I I I definitely wanted to ask about results, and you're telling us about results, but what I'm getting is big, amazing results, but not lots of them because you haven't tested them that much. It hasn't been done that much. But I'm gonna go back to a question that I have as a mom of somebody with schizophrenia, and that is from day one. And day one for me was 20 years ago. In all my discussions with doctors and providers and reading books and all the things that we do, the the story that I get is nobody really knows where schizophrenia is in your brain, nobody really knows what causes schizophrenia.
SPEAKER_03The um diagnosis is the diagnosis of criteria. Um we throw diseases, uh we throw medication off-label at the patient to see what works. And most medications are off-label things that were made for something else. So, how in the world do you know where to put something in a brain when we don't know where it is in the brain? Good question.
SPEAKER_01This is a this is a terrific question, right? And what I what I would answer, the way I would answer that is everything you said is true, uh, but at the same time, it's like not true, right? So it's like we don't know what causes schizophrenia, right? In your average patient. But we do know at the same time, schizophrenia is is there's the something is happening in the DNA that causes schizophrenia. So it's like we don't know, but we do know, right? Um we don't know why antipsychotics work, right?
SPEAKER_01But we do know that all antipsychotics that work share something in common and that they target the dopamine system, right? So it's like we don't know, but we do know we don't know where in the brain schizophrenia centralizes, we don't know if there is like a central location in the brain where like schizophrenia happens. There probably isn't. Um but we do know that like when a person hallucinates and hears a voice that's not there, certain areas of the brain like light up on MRI.
SPEAKER_01You know, so this is the frustrating thing about schizophrenia. It's like we don't know what's going on, but there's so much we do know at the same time. Um and I'd say like Know so how could you get to that point where it's like, here's this schizophrenia amongst all the illnesses in medicine that you encounter as a as a as a doctor, regardless of psychiatry, nephrology, whatever your specialty is, schizophrenia is one of the most complicated, severe illnesses that's out there.
SPEAKER_01So, how could you get to a point where it's like it's so complex and we don't really feel like we have a grasp on what's happening despite hundreds of years of research, but yet we feel comfortable putting an electrode in the brain to target a specific region? It's because it's like, well, first of all, it's like you have to do something, right? To do nothing, to be like, to be paralyzed by the complexity of the condition and how hard it is to know for certain what's happening. Um, you know, that's as researchers, we have to keep trying.
SPEAKER_01Um, and we know that deep brain stimulation um you know is incredibly effective in other contexts. So it's almost like here's something you talk about illness treatments that could be miraculous in other brain conditions. Well, here's the brain condition that puzzles us the most. We can't look away from DBS. We we have to say, okay, can DBS be effective for schizophrenia? And then it just takes someone to be the first to try for and and what you know for whatever enough information that made them try first, and then they see a promising signal, and then that's enough for the rest of us to say, okay.
SPEAKER_03It's fascinating. And so it's sounding like we're still treating the symptoms, right? This is not getting us closer to understanding why the hell this happens or where it's happening, but it's the same thing with tremors with Parkinson's. It doesn't cure the Parkinson's, but it enables a person to have a more palliative I I would settle for that as a mother.
SPEAKER_02I would settle for that if my son's symptoms were managed.
SPEAKER_03Oh, yeah, it's just everything's interesting to me that there's this.
SPEAKER_05So BS is like a like a light switch, right? We can turn on and off uh circuits or activity in circuits, and and when you turn off a certain circuit and it immediately resolves hallucinations, as has happened with several of our patients, you can you kind of know that at least that circuit is involved in their hallucinations. And yes, you don't really know what cost in the first place the abnormal firing in those um circuits. But the beauty about TBS, this is also where Alex's research comes in, is that you can then uh have the opportunity in these people to interrogate what happens in the brain, what changes in the brain, and that brings us for further to uh to to also understanding what may have been causal to those circuit abnormalities.
SPEAKER_04One thing that one oh go ahead.
SPEAKER_05We have to find patients that are brave enough to kind of be yeah, that lab red in a way, but it's it's it's it's I mean that's not an easy sell, but we have a good idea, as Alex explained, where in the brain things are probably going wrong with people that experience uh schizophrenia symptoms, and and and and that turned turned out to be be true so far for the patients that would be the ideal patient. Again, the ideal patient is a patient with chronic psychotic symptoms, I would say hallucinations and delusions that have not responded to medications or medications were too hard to tolerate, right?
SPEAKER_05Like with closureil. Yes, it's very effective, but sometimes it's just hard to tolerate. Um and again, they have to be invested, they have to also have an invested support system because it's brain surgery, you need to follow up on a monthly basis with our team. If something is not working correctly, we really want to know.
SPEAKER_03Um that's basically if a person has anasognosia, that wouldn't work, right?
SPEAKER_05They will have to have some insight, right? Yes, that it's that it's like a brain disease for which they will need a brain implant.
SPEAKER_04Uh oh my god. One thing we complain about with uh clozepine, we've got Dr. Leitman that helped us come up, help helped us have this program on this episode. You know, he's the chief complainer, but all of us do, that we wait till the last dog is hung and then finally we get the best antipsychotic. Do you think the day will come when regular people who aren't treatment resistant but are tired of ECT or tired of side effects of medication come and want this, but then they're not the ideal patient.
SPEAKER_04How do you think that will be reconciled in the future?
SPEAKER_05I mean, Parkinson's, where this has been around much longer, it's it's pretty common now, and it wasn't always that way, to have an implant in a very early stage where you are still working full-time and you just want to, you don't want to go that route of becoming treatment resistant and and and worsening of cognitions and all sorts of other symptoms. That's a very common trend now in parking sleep, especially in Europe. Um ideally, that would also be yeah the scenario for schizophrenia.
SPEAKER_05Um but it has to also be more reliable, right? If we know exactly uh how to uh how to target specific circuits that correlate with specific symptoms, I guess there will be a moment where with more confidence we can say, even if a patient doesn't believe it's gonna work, we'll still do it because we know it's gonna work. But we're not there yet. For now, we need someone that's really willing to uh to do an experiment in a way and give it a try.
SPEAKER_02Yeah, I can I so I have uh just a couple of little questions. First, a fantasy that I could just knock my son out, you know, just put him to sleep and hand them to you, and he'll wake up with uh deep brain stimulation. And I know that's unethical, but that's my fantasy as a mother. Like I know there are cultures where they sneak the medication into the food, but anyway, that's my fantasy. But my question is um is this available treatment or is this uh just in the research experimental stage?
SPEAKER_02Like how many people have you done this on, or has maybe there's there are other doctors doing this as well? And you know, or are you still amassing data?
SPEAKER_05It's highly experimental still. We've we've with uh the team of Hopkins and our own cyanide team, uh collectively, we've we've tried it in five people so far. So it's it's in a very early stage, and then there's a handful of patients around the world where it's been tried as well. So it's very it's a bit in a very early stage.
SPEAKER_04So the results So you said that it doesn't work for everybody. So how many of that, those five, did it work for?
SPEAKER_05I would say almost everybody, maybe except for one, but the rest have have all had a very meaningful response. We there was another patient that had also an acute resolution of their of their symptoms. Then there was a third patient with at least 50% reduction of symptoms, um, but she was able to function again. Um, uh there was a patient who did well, but then unfortunately had a relapse when he resumed smoking cannabis.
SPEAKER_05Um so he had to be uh readmitted. And um, so that's again it's in these five patients. I would say the majority is doing really well and uh and also very quickly, um but but it's still we still need to uh we need to further further uh investigate and explore. One of the things that we've also seen, and that's I think explainable by the fact that it's manipulating a wider circuit, is that also mood and negative symptoms and cognitive symptoms seem to improve.
SPEAKER_05It's too early to tell, but that would be highly promising, right? There's a treatment that not just treats psychosis but also the more negative and cognitive symptoms, and I think that's possible because DBS, unlike a medication, is very circuit selective, right? You can basically tune in and out circuits of choice, basically, if you implant strategically, which is of course never possible with medications. So that that's part of our research. Um, but I think it's promising.
SPEAKER_02Wow. So um so right now nobody can call up their doctor and go, I want DBS. Okay.
SPEAKER_05So they'll have to come to us in Sinai or to Hopkins uh and enroll in the trial.
SPEAKER_02Enrolling in the trial. So where do you think we're uh looking ahead five to ten years? And just so you know, we have about 10 minutes left on this podcast, and I want to give you a chance to say whatever we're not asking you, but I think you'll like to answer this question. Looking ahead five to ten years, we're I know things move slowly, so but where do you hope this will this will go in terms of schizophrenia treatment in the future?
SPEAKER_05Yeah, in five years, I think we're we're gonna be ready because we'll we'll have tested this treatment in enough people uh to basically trust uh what we've seen so far that it really works uh to do a randomized control trial. That's always needed to make it into approved treatment. Uh and that's gonna probably take another five years. So I think in ten years, hopefully this will be something that people can get clinically.
SPEAKER_01I th I think that in addition to the clinical treatment, the opportunity uh for uh the world uh of people who s who are affected by schizophrenia, whose lives are touched by schizophrenia, um is uh is is pretty uh immense here. Um when a treatment is available that requires accessing the brain itself, you have this window of opportunity for patients who who want to um to participate in this additional component of the of the program uh to allow us to to ask questions about what is happening in schizophrenia at the deepest level in a way that you can never ask uh about the illness in people who don't get brain surgery.
SPEAKER_01You you actually are uh accessing the brain itself. Um so for example, um in other illnesses uh that we use DBS to to treat um as a treatment, uh during the procedures we we we do uh sh short uh kind of um uh um uh research activities to learn something about the illness. Um so you can imagine someone who's getting DBS for the treatment of schizophrenia, like I like we talked about, during the procedure they're awake.
SPEAKER_01So someone could be hallucinating on the operating table while a surgeon is like looking at their brain. Yeah, we we could be recording um how neurons are firing in a person's brain while they're hallucinating in a way, you know, this is different than like putting them in an MRI scanner. You're talking about the brain itself, you know, and you know, in a couple of patients, could you really learn something fundamental about schizophrenia by doing that? You know, two, three patients, probably not.
SPEAKER_01But 10 years from now, if if even just as part of research, you know, say 100 patients have gotten the procedure under a clinical trial, well, we might be able to learn something fundamental about schizophrenia from those 100 people.
SPEAKER_04My last question, and by the way, I'm glad you two look young, but you can for those who aren't watching this on YouTube, I think they can make it for 10 years and more to finish this up. Um, but my question is about funding. Um, you know, to do research and universities are under attack at times in terms of funding. I'm wondering who's funding this because often research is funded by pharmaceutical companies unless you can get funding from the federal government.
SPEAKER_04Um, and so I how is how what interest groups, if any, are funding this? And then also, is there any resistance from pharmaceutical companies if they see this coming down the pike and that would mean uh less profit for uh uh psychmeds?
SPEAKER_01Yeah, the right now it's completely funded by uh philanthropists uh to Mount Sinai. Um and you know our philosophy is basically we're gonna find a way. Uh, you know, whether it's philanthropy, whether it's NIH, um, you know, uh when the tide turns and the funding situation NIH is more favorable, whether it's you know, partnerships with companies that are somehow involved in the DBS space, we figure out a way to get it done. Um you know, right now it's being uh completely funded by philanthropy.
SPEAKER_01Um I'm I'm interested to hear what what what Martin thinks. Uh I think the number of patients who who would get DBS is not large enough to really be on the radar of a big pharma company that's developing a drug that millions of patients are going to take. So they probably don't care uh, you know, if DBS makes it all the way to being a standard of care, because in the end, it it's always gonna be an option for people who failed everything else.
SPEAKER_04I so you don't see it for for the general public to short circuit all the other treatments.
SPEAKER_01Well, I well, so so uh let me combat that a little bit. There's always gonna be requirements before insurance is gonna cover the treatment, like even if it becomes a standard of care, insurance can accompany. Yeah, they're not gonna be eager to be like, sure, we'll pay for the surgery if you haven't tried like how dog. Right, right. Um, you know, so there's always gonna be some step before the surgery. Um, and that step's gonna be a medication.
SPEAKER_02Okay. I I I do want to just quickly repeat something you said before, and I don't want to veer off into this, but we here on this podcast are very anti-cannabis. Uh maybe we didn't used to be, but we are, and we've learned a lot in doing 143 episodes. So I found it very interesting that you found that even DBS could be interfered with by cannabis.
SPEAKER_05Yeah.
SPEAKER_02So do you both feel uh cannabis is not a good idea for people with schizophrenia?
SPEAKER_05Yeah, I'm afraid it's not the best combination.
SPEAKER_02Yeah.
SPEAKER_01I mean, cannabis is a is a is a drug that causes psychosis in in people who don't have schizophrenia. And uh yeah, it's very dangerous for people with schizophrenia, in my opinion. Yeah.
SPEAKER_04Thank you. You won't get any arguments from us. No, we're not gonna argue.
SPEAKER_02So, you know, um and and Mimi, I know you have to go in a minute, so i if there's a question you want to ask, I'll give you a chance before you run out. But you if you were speaking and I I'm really glad to hear this is happening, and thank you for your interest and your hard work on this, because this is very exciting and I know it's in the future. Um, I do want to give you a chance to uh tell us how people can volunteer for the study in a minute, but I just want to ask you this if you were speaking directly to somebody like us, a mother whose adult child has severe treatment resistant schizophrenia, and she's exhausted, what would you want her to know about where the science is today?
SPEAKER_01You know, I I I I would say I'm gonna get emotional here. Um you know, that's schizophrenia as as you know, as a historian of of the illness myself, in addition to being someone who studies it, you know, and is is my whole life is is centers around this illness, um is is despite the lack of progress in the field, it seems like in every generation there's there's scientists who just can't think about anything else. And I don't think it's ever gonna change.
SPEAKER_01It's just an illness that um when when it when when you uh when it captures your imagination or or touches your life in some way as a as a as a clinician, it's hard to think or focus on anything else. Um and that's I think the um there's there's people there's there's people like that throughout the world, you know, myself, Dr. Frighier, two of them, Dr. Leipman, of course. Um and I think that's always gonna be the case.
SPEAKER_01And no matter how hard um it is, no matter how much time passes where it feels like progress is so slow, every generation views that as an opportunity. Um and I don't think the field's ever gonna stop. If schizophrenia is a focus of the biomedical research community um in every generation that doesn't seem to be losing steam ever, um, no matter how frustrating it gets. And I, you know, it's it's not the best reassurance because it's not like I wish I could say, oh, there's something coming out soon that's gonna cure the illness.
SPEAKER_01Um, but I I don't have any doubt that like the field is never gonna give up on schizophrenia. It's like cancer. You know, no, no one's gonna ever give up on trying to solve this incredibly mysterious condition.
SPEAKER_04I'm glad to hear that because sometimes families like us don't always feel that way. I don't think we hear enough about what's going on.
SPEAKER_01So this program is it's very different when I'm treating patients in the clinic versus when I'm thinking about schizophrenia as a researcher. You know, it's just different because it's it's a different experience for the patient, right? You know, it's it's like in the clinic when I'm just treating patients day to day, I you know, I have I have the antipsychotics, there's and you know what I can offer them as a human being, I don't I can't really, you know, reassure I can't fix their illness by talking to them about what could happen 100 years from now, you know what I mean?
SPEAKER_01Yeah.
SPEAKER_02Martine, looks like you want to add something.
SPEAKER_05Well, yeah, when you've seen what Alex and I've seen in in these acute dramatic responses uh in patients with a well-placed electrode into their brain, that's so enormously motivating. I I'm motivated, I'm whenever I see a patient, doesn't matter how severe, I'm always motivated because I know in the end there is a solution. Yeah, and there is something that we can find. And I've seen now so many examples of that. I mean, I'm absolutely motivated.
SPEAKER_05I know that's probably a little harder from a distance, or if it's um if it's if it's your your family member, but I would say, like Alex, I would echo stay hopeful. I think we're we're entering a a great uh era where we're learning so much about it.
SPEAKER_01It does, it does feel like, and I'm sure people feel this in every generation, it feels like we're on the cusp.
SPEAKER_05Yeah.
SPEAKER_01You know, it feels like with between electrical stimulation through deep brain stimulation, our knowledge of the genetics, um, advancing technology when it comes to designing new types of drugs, it feels like we're on the cusp. And and you know, within the next 20 years is gonna be way more um uh uh fruitful when it comes to new options coming online for people than the last 20.
SPEAKER_02That's wonderful. Um thank you. How can people help? How can are you looking for subjects? Where do they go for information and possibly to volunteer?
SPEAKER_01Yeah, I think we shared uh that there'll be a URL in the in the in the notes for the podcast for a website um to that could connect them to Martin and I. Um they could yeah, if they're if our names are in the notes, they'll be able to just Google us and find out how to contact us. We're not we're not hard to find. You know, we're on we're online. Um yeah.
unknownYeah.
SPEAKER_02All right, thank you. Mimi, Mindy, any last-minute words or Dr. Leightman, any last-minute thoughts before we close? This has been amazing.
SPEAKER_04I just say thank you. Thank you for doing this with such passion.
SPEAKER_00I knew you guys would enjoy it, and it really just brings more hope. And uh we, as you guys know, um we have a few people that we are trying to convince to come your way because they despite our best efforts, um, you know, uh and with my best efforts, it's always clozapine plus ECT are very symptomatic and meet the criteria for informed consent.
SPEAKER_00It's just convincing them to come. So they watch three moms in the trenches. So in my planning, um, I was uh trying to um give you guys a platform, and I I think you knocked it out of the park. So I really appreciate you guys coming on, and of course, I appreciate my my three moms as it is. We appreciate you, three moms.
SPEAKER_03You know, I I'd like to just say also, just really like thank god you guys are here, all three of you guys, you know, and and the fact that you're obsessed with it or committed to or whatever, this particular conundrum is the thing that gives us hope. And I I just have a question, you know, there's a thing my family participated in a genome study at NIH many years ago when they were still funding more things, and the whole family did it, and the Nick's sisters did it too, and they said it was really great because they don't usually get full siblings and both parents, and because of the disaster that schizophrenia itself, you know, leaves behind.
SPEAKER_03And um, another thing that I did through them is I signed up to donate my brain to science, which is a cause of great amusement among my family. But I but I felt like, wow, maybe that's something I could do that in the future might make a difference for somebody because who the hell thinks of doing something that so I would just like to say that out there to our moms, genome studies, studies where you can participate, where siblings can participate, donate your damn brain to science.
SPEAKER_03Do whatever you can do because it'll get us there faster, and maybe this suffering will ease. So that's my pitch.
SPEAKER_02That is a great note to end on. I just have Alex and Martin and I just want to thank you so much, Dr. Leitman, Rob, thank you so much for joining us today and for giving us hope.
SPEAKER_01Thank you. Hey, you know, the schizophrenia, it's a small community. We got to stick together. Thanks for having us here.
SPEAKER_02Thank you so much for tuning into this episode of Schizophrenia Three Moms in the Trenches. You can help out the podcast and help others by sharing the podcast and by subscribing wherever you get your podcasts and or on YouTube. And remember, you can reach us at mindygryling.com, randy k dot com, or MiriamHyffenfeldman.com.
Send a Text to the Moms - please include your contact info if you want a response. thanks! Supported Decision-Making (SDM) is an alternative to guardianship that allows individuals with disabilities to retain their...
Send a Text to the Moms - please include your contact info if you want a response. thanks! This episode focuses on the Fairweather Lodge model as implemented by Tasks Unlimited in Minnesota, highlighting its success in...
Send a Text to the Moms - please include your contact info if you want a response. thanks! Available Monday Through Friday, 10:00 AM - 10:00 PM ET You Are Not Alone. We are here to help. The NAMI Family Caregiver...
Send a Text to the Moms - please include your contact info if you want a response. thanks! Technology is changing the way we think about mental health care - but what does that mean for families living with...
Send a Text to the Moms - please include your contact info if you want a response. thanks! Guest: Allen Giese, author of When Mental Illness Strikes: Crisis Intervention for the Financial Plan The episode of...